Xconomy San Diego — Gossamer Bio’s direct drug, an experimental cure for asthma and allergies, has unsuccessful in two mid-stage clinical trials but the biotech sees adequate in the information to go after further more advancement in a severe type of asthma and it wants to chat with regulators about […]